News for B-SMART

In recent years, messenger RNA (mRNA) has gained global recognition, largely due to its pivotal role in the development of COVID-19 vaccines. The sign...

Over more than five years, the recently concluded Horizon 2020 project B-SMART explored novel ways to deliver RNA nanomedicines to the brain to treat...

The EU-funded project B-SMART that aimed at designing and manufacturing modular nanoparticles over the last 5+ years, has ended. Over the last few pro...

Between 24 and 25 January 2022, the B-SMART consortium gathered for another virtual progress meeting. Representatives from all partners were present a...

B-SMART has released short interview clips with young scientists from their consortium. Illustrating the project’s innovative approach and raising awa...

From 27-28 January 2021, the B-SMART consortium gathered for another virtual progress meeting. All partners are by now well-versed in conducting such...

The success of the technology used in the vaccine candidates against COVID-19 developed by Moderna and Pfizer/BioNTech, which are currently in late-st...

European researchers take nanotech-based therapies from the lab to the clinic

For the first time since the start of the project in 2017, the consortium had to gather for an online progress meeting: Due to the COVID-19 pandemic,...

With the end of their second reporting period, the B-SMART consortium had another appointment with their EC Officer in Brussels: The project was evalu...

Towards new RNA therapeutics targeting neurodegenerative diseases

3rd Progress and 1st Review Meeting in Aprilia, Italy

Joint dissemination initiative in cooperation with H2020 project Starbios2

New RNA therapeutics address the direct cause of neurodegenerative diseases like Alzheimer's